Bendigo Health

Bendigo, Victoria 3551

3 studies enrolling now · 8 studies all time

What they study most

Asthma Acute, COPD Acute Exacerbation, Cutaneous Squamous Cell Carcinoma, Gastrointestinal Hemorrhage (Clinically Important, Upper), Locally Advanced and Metastatic Solid Tumors, Metastatic Prostate Cancer, Staphylococcus Aureus Bacteremia, Triple Negative Breast Cancer

Studies at this site

• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) — Recruiting now
• Study of ORIC-944 in Patients With Metastatic Prostate Cancer — Recruiting now
• Staphylococcus Aureus Network Adaptive Platform Trial — Recruiting now
• Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma) — Running, not enrolling
• Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD) — Running, not enrolling
• Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma — Running, not enrolling
• Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors — Completed
• Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial — Completed